Overview
In the last few years, there has been an evident rise in the global disease burden. More importantly, the inability to report a health issue to a medical practitioner in its initial stages is expected to cost over USD 90 billion in excess and more than USD 40 billion in productivity loss, each year. Moreover, a number of individuals that are required to frequent hospitals for monitoring of their health conditions, such visits cause additional financial burden. The aforementioned concerns can be mitigated by shifting to a home-based care setting. Amidst the recent initiatives in this context, remote patient monitoring (RPM) has emerged as a potent and sought-after alternative in the healthcare industry. During the COVID-19 pandemic, the healthcare industry evolved significantly, due to the need and urgency to treat patients with the aid of telemedicine and digital platforms. Remote Patient Monitoring (RPM) technologies enable monitoring of patients virtually for a wide range of diseases from anywhere around the globe. It is worth mentioning that large volumes of health data can be accessed by medical researchers on dedicated cloud servers that have been designed to comply with the Health Insurance Portability and Accountability Act (HIPAA) of 1996. In addition to improved quality of care and better access to the patients, remote patient monitoring (RPM) offers ease of implementation, leading to substantial time and cost saving (by eliminating the need for transportation and waiting in queue to meet the physician).
Considering the various advantages offered by remote patient monitoring (RPM), healthcare organizations are gradually becoming more receptive to adopting such software solutions for their regular use. As a matter of fact, the recent surge in demand for remote monitoring amidst the COVID-19 pandemic has served to create a strong case for organizations to shift to the use of remote patient monitoring consultation tools and software. In fact, a recent study stated that over 50% of the healthcare consumers would consider using remote patient monitoring (RPM) solutions as a part of their medical treatment, if recommended by their physician. Over the years, telemedicine start-ups have seen a significant growth. These companies are engaged in providing tailored solutions, along with remote access of medical care facilities to the patients. It is worth mentioning that around 90% of the healthcare organizations have either invested or intend to invest in remote patient monitoring systems. Given the rising trend of remote patient monitoring software solutions in the healthcare industry and the ongoing efforts of software providers to further improve/expand their respective offerings, we believe that the remote patient monitoring consultation tools and software providers market is likely to evolve at a steady pace, till 2030.
Scope of the Report
The “Telemedicine Tools and Software Providers Market: Focus on Remote Patient Monitoring, 2021-2030, Distribution by Area of Application (Blood Glucose, Blood Pressure, Body Temperature, Electrocardiogram, Oxygen Saturation, Respiration Rate, and Others), Therapeutic Areas (Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders, Respiratory Disorder, and Others), Product/Software Purpose (Commercial Purpose and Clinical Purpose), Type of Business Model (B2B and B2C), and Geography (North America, Europe, Asia-Pacific, Latin America, and MENA)” report features an extensive study of the current market landscape and the likely future potential of the remote patient monitoring software providers market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.
Amongst other elements, the report features:
- A detailed overview of the overall market landscape of players engaged in providing remote patient monitoring consultation tools and software, along with the information on several relevant parameters, such as year of establishment, company size, location of headquarters. Further, it highlights a detailed assessment of the overall market landscape of more than 200 consultation tools and software based on several relevant parameters, such as type of software (software as a system and software as a service), area of application (blood glucose, blood pressure, electrocardiogram (ECG), oxygen saturation, respiration rate, temperature, and others), therapeutic areas (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and other disorders), product/software purpose (commercial purpose and clinical study purpose), type of telemedicine operation (store-and-forward, remote monitoring, and real-time), type of remote patient monitoring service (data collection, transmission, evaluation, and notification), type of business model (B2B and B2C).
- Elaborate profiles of prominent players (shortlisted based on number of software being offered by mid-sized and large players established before 2010) engaged in the development of remote patient monitoring software. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters, key executives, financial details/information (if available), product portfolio, recent developments and an informed future outlook.
- An analysis of the recent partnerships inked between remote patient monitoring software providers, during the period 2015-2021 Additionally, it includes a brief description of the various types of partnerships models (such as product/software integration agreement, service alliance, service agreement, product/software development agreement, full business acquisition, product/software distribution agreement, product/software utlilization agreement, and product portfolio acquisition) that have been adopted by stakeholders engaged in this domain, during the period 2015-2021.
- A detailed analysis of various investments made by players engaged in this domain based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (such as, venture capital, private equity, secondary offerings, debt, initial public offering (IPO), other equity, seed, grant, and others), along with information on the most active players (in terms of number of funding instances and amount raised) and most active investors (in terms of number of funding instances).
- An in-depth product competitiveness analysis of remote patient monitoring software based on supplier power (in terms of expertise of the developer) and key product-related specifications (such as status of development, HIPPA compliant, type of software, area(s) of application, number of therapeutic areas, purpose of software, number of patient monitoring related services, type of telemedicine operation, and type of business model).
- An insightful analysis highlighting the likely cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, taking into consideration various parameters, such as number of patient visits (in-patient and out-patient) and increase in efficiency by adoption of remote patient monitoring software solutions.
- An elaborate discussion on how the recent COVID-19 pandemic is likely to impact the remote patient monitoring software market, along with information on the key initiatives undertaken by players engaged in this domain to overcome the challenges faced due to the pandemic.
- A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall remote patient monitoring tools and software providers industry.
One of the key objectives of this report was to evaluate the current opportunity and the future potential associated with the remote patient monitoring consultation tools and software providers market, over the coming decade. We have developed an informed estimate on the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] area of application (blood glucose, blood pressure, ECG, oxygen saturation, respiration rate, temperature, and others) [B] target therapeutic area (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and others), [C] software purpose (commercial purpose and clinical study purpose), [D] type of business model (B2B and B2C), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA (Middle East and North Africa)). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Key Questions Answered
- Who are the leading players engaged in the development of remote patient monitoring tools and software?
- Which type of software is most commonly offered by remote patient monitoring consultation tools and software providers?
- Which kind of partnership models are commonly adopted by stakeholders engaged in this industry?
- What is the relative competitiveness of different remote patient monitoring software solutions?
- What is the likely cost saving potential associated with the use of remote patient monitoring software?
- What are the key challenges currently faced by stakeholders in this industry?
- What are the anticipated future trends related to remote patient monitoring consultation tools and software providers?
- How is the current and future market opportunity likely to be distributed across key market segments?
- What is the likely impact of the ongoing COVID-19 pandemic on the overall remote patient monitoring market?
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Telemedicine
3.2.1. Store-and-Forward Telemedicine
3.2.2. Real-Time Telemedicine
3.2.3. Telemedicine in Remote Patient Monitoring
3.3. Advantages of Remote Patient Monitoring
3.4. Limitations Associated with Remote Patient Monitoring
3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
3.6. Concluding Remarks
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
4.2.1. Analysis by Type of Software
4.2.2. Analysis by Purpose of Software
4.2.3. Analysis by Area of Application
4.2.4. Analysis by Therapeutic Area
4.2.5. Analysis by Type of Telemedicine Operation
4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
4.2.7. Analysis by Type of Business Model
4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. Players based in North America
5.2.1. BioTelemetry
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Software Portfolio
5.2.1.4. Future Outlook
5.2.2. LeewayHertz
5.2.2.1. Company Overview
5.2.2.2. Software Portfolio
5.2.2.3. Future Outlook
5.2.3. Masimo
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Software Portfolio
5.2.3.4. Future Outlook
5.3. Players based in Europe
5.3.1. Braster
5.3.1.1. Company Overview
5.3.1.2. Software Portfolio
5.3.1.3. Future Outlook
5.3.2. LifeWatch
5.3.2.1. Company Overview
5.3.2.2. Software Portfolio
5.3.2.3. Future Outlook
5.3.3. Medtronic
5.3.3.1. Company Overview
5.3.3.2. Financial Information
5.3.3.3. Software Portfolio
5.3.3.4. Future Outlook
5.3.4. Siemens Healthineers
5.3.4.1. Company Overview
5.3.4.2. Financial Information
5.3.4.3. Software Portfolio
5.3.4.4. Future Outlook
5.4. Players based in Asia-Pacific
5.4.1. Transtek Medical
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Software Portfolio
5.4.1.4. Future Outlook
6. PARTNERSHIPS AND COLLABORATIONS
6.1. Chapter Overview
6.2. Partnership Models
6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
6.3.1. Analysis by Year of Partnership
6.3.2. Analysis by Type of Partnership
6.3.2.1. Analysis by Year and Type of Partnership
6.3.2.2. Analysis by Type of Partnership and Company Size
6.3.3. Analysis by Type of Software
6.3.3.1. Analysis by Year of Partnership and Type of Software
6.3.3.2. Analysis by Type of Partnership and Type of Software
6.3.4. Most Active Players: Analysis by Number of Partnerships
6.3.5. Regional Analysis
6.3.5.1. Intercontinental and Intracontinental Agreements
7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding
7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
7.3.1. Analysis by Cumulative Year-wise Trend, 2015 - 2021
7.3.2. Analysis by Amount Invested
7.3.3. Analysis by Type of Funding
7.3.3.1. Analysis by Type of Venture Capital Round
7.3.4. Analysis by Type of Software
7.3.5. Analysis by Focus Area
7.3.6. Analysis by Geography
7.3.7. Most Active Players: Analysis by Number of Instances
7.3.8. Most Active Players: Analysis by Amount Invested
7.3.9. Most Active Investors: Analysis by Number of Instances
7.3.10. Analysis by Year, Amount Invested and Type of Investor
7.4. Concluding Remarks
8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness: Software as a Service
8.5. Product Competitiveness: Software as a System
9. COST SAVING ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Methodology
9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential
9.3.1. Likely Cost Savings in North America, 2021-2030
9.3.2. Likely Cost Savings in Europe, 2021-2030
9.3.3. Likely Cost Savings in Asia, 2021-2030
9.3.4. Likely Cost Savings in Rest of the World, 2021-2030
9.4. Conclusion
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, 2021-2030
10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, 2021-2030
10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, 2021-2030
10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, 2021-2030
10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, 2021-2030
10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, 2021-2030
10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, 2021-2030
10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, 2021-2030
10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, 2021-2030
10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, 2021-2030
10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, 2021-2030
10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, 2021-2030
10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, 2021-2030
10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, 2021-2030
10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, 2021-2030
10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, 2021-2030
10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, 2021-2030
10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, 2021-2030
10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, 2021-2030
10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, 2021-2030
10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, 2021-2030
10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle-East and North Africa (MENA), 2021-2030
10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, 2021-2030
11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET
11.1. Chapter Overview
11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
11.3. Recuperative Initiatives of Key Players
11.4. Recuperative Strategies for Businesses
11.4.1. Strategies for Implementation in the Short / Mid Term
11.4.2. Strategies for Implementation in the Long Term
12. SWOT ANALYSIS
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Comparison of SWOT Factors
13. CONCLUSION
14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. AltumView System
14.2.1. Company Snapshot
14.2.2. Survey Transcript: John Wu, Co-Founder
15. APPENDIX I: TABULATED DATA
16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
List of Figures
Figure 3.1 Type of Telemedicine
Figure 3.2 Steps Involved in Remote Patient Monitoring
Figure 3.3 Key Benefits and Limitations of RPM Solutions
Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
Figure 5.1 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Figure 5.2 Masimo: Annual Revenues, 2015-2021 (USD Million)
Figure 5.3 Medtronic: Annual Revenues, 2015-2021 (USD Million)
Figure 5.4 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Figure 5.5 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Figure 6.8 Most Active Players: Distribution by Number of Partnerships
Figure 6.9 Partnerships and Collaborations: Regional Distribution
Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
Figure 7.11 Funding and Investment Analysis: Distribution by Geography
Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Figure 7.13 Most Active Players: Distribution by Number of Instances
Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 7.15 Most Active Investors: Distribution by Number of Instances
Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Figure 8.1 Product Competitiveness Analysis: Software as a Service
Figure 8.2 Product Competitiveness Analysis: Software as a System
Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Figure 11.1 Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)
Figure 11.2 Key RPM Consultation Tools and Software Providers
Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Concluding Remarks: Current Market Landscape
Figure 13.2 Concluding Remarks: Recent Partnerships
Figure 13.3 Concluding Remarks: Funding Analysis
Figure 13.4 Concluding Remarks: Cost Saving Analysis
Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography
List of Tables
Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
Table 5.1 BioTel Care: Company Overview
Table 5.2 BioTel Care: Software Portfolio
Table 5.3 BioTel Care: Future Outlook
Table 5.4 LeewayHertz: Company Overview
Table 5.5 LeewayHertz: Software Portfolio
Table 5.6 Masimo: Company Overview
Table 5.7 Masimo: Software Portfolio
Table 5.8 Masimo: Future Outlook
Table 5.9 Braster: Company Overview
Table 5.10 Braster: Software Portfolio
Table 5.11 LifeWatch: Company Overview
Table 5.12 LifeWatch: Software Portfolio
Table 5.13 LifeWatch: Future Outlook
Table 5.14 Medtronic: Company Overview
Table 5.15 Medtronic: Software Portfolio
Table 5.16 Medtronic: Future Outlook
Table 5.17 Siemens Healthineers: Company Overview
Table 5.18 Siemens Healthineers: Software Portfolio
Table 5.19 Siemens Healthineers: Future Outlook
Table 5.20 Transtek Medical: Company Overview
Table 5.21 Transtek Medical: Software Portfolio
Table 5.22 Transtek Medical: Future Outlook
Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, 2015-2021
Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, 2015-2021
Table 7.2 Funding and Investment Analysis: Summary of Investments
Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
Table 14.1 AltumView System: Company Snapshot
Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
Table 15.14 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Table 15.15 Masimo: Annual Revenues, 2015-2021 (USD Million)
Table 15.16 LifeWatch: Annual Revenues, 2015-2021 (USD Million)
Table 15.17 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Table 15.18 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Table 15.26 Most Active Players: Distribution by Number of Partnerships
Table 15.27 Partnerships and Collaborations: Regional Distribution
Table 15.28 Partnerships and Collaborations: Country-wise Distribution
Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
Table 15.40 Funding and Investment Analysis: Distribution by Geography
Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Table 15.42 Most Active Players: Distribution by Number of Instances
Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.44 Most Active Investors: Distribution by Number of Instances
Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Table 15.79 Telemedicine in Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 100Plus
- 1812 Ventures
- 19Labs
- 3M Ventures
- 3one4 Capital
- 42Gears Mobility Systems
- 500 Startups
- A&D Medical
- Abbott
- Acceleration Fund
- AccessibleRPM
- Acetiam
- Adelie
- AdvaMed Accel
- Aerotel Medical Systems
- Agatsa Software
- AGNITY Healthcare
- Ai Health Highway
- AloT Health
- AliveCor
- Aloe Care Health
- Alpana Ventures
- AltumView Systems
- Amadeus Capital Partners
- AMC Health
- American Heart Association (AHA)
- AMN Healthcare
- Amwell
- Anathem Ventures
- Anelto
- Anges Québec
- Anthem Capital
- Aperture Venture Partners
- Aphelion Capital
- Archimedia
- ARTIS Ventures
- Asahi Intecc
- Ascension Ventures
- Ascent Biomedical Ventures
- Ascom
- AstraZeneca
- athenahealth
- Atlantic Bridge
- Audicor Cardiometrics
- Aurora Health Care
- Aviva Ventures
- AVS Medical
- Axilor
- Babylon Health
- Babyscripts
- Bank of the Philippine Islands (BPI)
- Bardy Diagnostics
- Baxter Ventures
- Bayer
- BDC Capital
- BeatO
- Ben Franklin Technology Partners
- BettrLife
- Bill & Melinda Gates Foundation
- BioAdvance
- Biobeat
- Biofourmis
- BioIntelliSense
- BioNTech
- BioSerenity
- Biotechnology Industry Research Assistance Council
- BioTel Care
- BioTelemetry
- Biotricity
- Bizmatics
- Black Pearl Global Investments
- Blue Cross Blue Shield
- Blue Spark Technologies
- Blume Ventures
- BNP Paribas Développement
- Bold Capital Partners
- Bonfire Ventures
- Boston Scientific
- Bpifrance
- Brainpan Innovations
- Braster
- Bristol Myers Squibb
- Cambia Health Solutions
- Canaan Partners
- Capital Factory
- Capsule Technologies
- CAPTUREPROOF
- Cardinal Health
- Cardiomo
- Cardiotrack
- Cardiovascular Systems
- Care Innovations
- CareClix
- Caregility
- Carematix
- CareMonitor
- CarePICS
- CareSignal
- CareSimple
- Catex Health
- Cathexis Ventures
- Centre for Development of Advanced Computing (C-DAC)
- Cerner
- Certintell
- CG Health Ventures
- ChartSpan
- Chiron Health
- ChronicWatch
- ChroniSense Medical
- Claris Healthcare
- Cloud DX
- Cohero Health
- Comarch
- Compass Medical
- Contact Doctor Healthcare
- Cover2protect
- Cultivation Capital
- Curatess
- Curatio
- Current Health
- Daher Capital
- DarioHealth
- Dassault Systèmes
- DaytoDay Health (DTDHI)
- DCM Ventures
- Delphi Ventures
- Department of Science and Technology
- Device Authority
- Dexcom
- Diagnext
- Digital Technology Supercluster
- Digitalis Ventures
- DigiTx Partners
- Diversified Healthcare Partners
- Doccla
- DocEngage
- Doconvid AI
- Dozee
- Dräger
- Dreamit Ventures
- Drimpy
- DVI Equity Partners
- EDBI
- Edison Partners
- Eko
- Elements Health Ventures
- Endeavour Vision
- Enterprise Ireland
- Envolve People Care
- eVisit
- Eurazeo
- FedDev Ontario
- FirstLight Home Care
- Floodgate
- Forefront Analytics
- Fosun Pharma
- FOUNDER.org
- Founders Fund
- Foundry
- Francisco Partners
- Fresenius Medical Care North America
- Froedtert & the Medical College of Wisconsin
- Frontline Strategy
- Frontline Ventures
- FundersClub
- Fuse Medical
- Gallagher Home Health Services
- GatewayMD
- Georgian Partners
- Gilde Healthcare
- GIS Strategic Ventures
- Global Telehealth Services
- Glooko
- Grapheal
- Grazia Equity
- Great Lakes NeuroTechnologies
- Greenspring Associates
- Grove Ventures
- GrowAyu Technologies
- GYANT
- Hale Health
- HAT Technologies
- Health Catalyst Capital
- H-Connect
- Health Enterprise Partners
- Health Recovery Solutions (HRS)
- Health Sensei
- HealthArc
- HealthCare Ventures
- Healthcom
- HealthKOS
- HealthQuest
- HealthX Ventures
- HealthyGx
- Heitkamp & Thumann
- Henry Schein
- Hicuity Health
- Highland Capital Partners
- Higi
- Hikma Ventures
- Hitachi Ventures
- HNC Virtual Solutions
- Hoy Health
- Huma
- HumanITcare
- ICON
- iHealth Labs
- iHealthHome
- Implicity
- Indian Angel Network (IAN)
- Info360degree
- Inhealthcare
- Inkblot Labs
- Innovaccer
- Inova Health System
- Insight Partners
- INSUD PHARMA
- Insulet
- InteliChart
- Intermountain Ventures
- Invest Partners
- IOTA Informatics
- IP Group
- IPF Partners
- IQ Capital
- iRhythm Technologies
- Isansys Lifecare
- Itochu
- Jianke
- JNC Medical
- Johnson & Johnson
- Kaiser Permanente
- Karantis360
- Kayan Health
- Keva Health
- Khosla Ventures
- KickstartFund
- Kinled Holding
- Koninklijke Philips
- Kratin
- Kurma Partners
- LabCorp
- Laboratory Silicon Valley
- Lacuna Health
- LBO France
- LeewayHertz
- Legal & General
- Leo Capital
- Lifelight
- LifeWatch
- LionBird
- LLR Partners
- LRVHealth
- LSP
- Lumeon
- Lumira Ventures
- m.Care
- m.Doc Smart Clinic
- Manchester Capital Management
- Manorama Infosolutions
- Maple
- Martin Ventures
- Masimo
- MassChallenge
- MassMutual Ventures
- MAXIS Global Benefits Network
- Mayo Clinic
- MedAxiom
- Medically Home
- MediOrbis
- MedIoTek Health Systems
- MedM
- MedTech Innovator
- MEDTEQ+
- Medtronic
- Merisis VP
- MicroPort CRM
- Mindray Medical International
- MMC Ventures
- MobileHelp
- Moderna
- Mor Provident Fund
- Mosio
- mTelehealth
- MTIP
- Murata Vios
- MVM Life Science Partners
- MyVitalz
- Nanowear
- Nantahala Capital Management
- National Institute for Health Research (NIHR)
- National Research Council Canada
- National Science Foundation (NSF)
- NemoCare Wellness
- NeuralRays AI
- New Enterprise Associates
- Newark Venture Partners
- NewYork-Presbyterian Hospital
- NGen
- NHSX
- Nihon Kohden
- Northampton General Hospital Trust
- Northpond Ventures
- Northwell Health
- Norwich Ventures
- Novo Nordisk
- NTTVC
- NueCura Partners
- NWS Holdings
- NXgenPort
- OBS Medical
- ODDO BHF Private Equity
- Olipan Investments
- Olive Tree Ventures
- Omada Health
- OMRON Healthcare
- Openspace Ventures
- OpenTeleHealth
- OpenView Venture Partners
- Optimize Health
- Optum Ventures
- Orb Health
- OrbiMed Advisors
- Orbita
- Orios Venture Partners
- OSF HealthCare
- Oxehealth
- Oxford Finance
- Oxford Sciences Innovation
- Oxitone Medical
- P5 Health Ventures
- Par Equity
- Paris Saclay Seed Fund
- PatientLink
- Peerbridge Health
- Perceptive Advisors
- Peter Thiel's Founders Fund
- Pfizer
- Pfizer Healthcare Hub
- PharmEasy
- PHC Holdings
- Philips
- Phoenix Insurance
- PhysIQ
- Ping An Insurance
- Plug and Play
- Podimetrics
- Polaris Partners
- Prairie Crest Capital
- Prime Venture Partners
- Promantra Synergy Solutions
- Psagot Investment House
- PSIM
- PurpleRibbon Healthcare Services
- Qardio
- Qualcomm Life
- Qualcomm Ventures
- Questa Capital
- Qumra Capital
- Qure Ventures
- RED Medical Systems
- Redox
- Reliq Health Technologies
- Remote Care Partners
- Resideo Life Care Solutions
- ResMed
- Rex Health Ventures
- Rimidi
- Rinicare
- River Cities
- Roche
- Rock Health
- Rockstart
- RPM in a Box
- RTP Ventures
- SaaS Capital
- Samsung
- Samsung NEXT
- Sanford Health
- Scientific Health Development
- Scottish Investment Bank
- SeamlessMD
- Section 32
- Senseonics
- Sensogram Technologies
- Sensome
- Sequoia Capital
- Seraph
- SGInnovate
- Shea Ventures
- Shenzhen Capital
- Siemens Healthineers
- Silicon Valley Bank
- Sinopharm
- Sinovac Biotech
- Siren
- Smith+Nephew
- Smiths Medical
- Social Capital
- SoftBank Vision Fund
- Soleus Capital
- Somatix
- Sony Innovation Fund
- SOSV
- Spacelabs Healthcare
- Spectrum Health
- Spry
- Square 1 Bank
- St. Luke’s Medical Center
- StartX
- StartUp Health
- Stasis Labs
- Strados Labs
- SV Health Investors
- Swanhill Capital
- TaiDoc Technology
- Technology Development Board (TDB)
- techstars
- Teladoc Health
- TeleMedCare
- Teslon Technologies
- Three Leaf Ventures
- TiaTech Health Technologies
- Tiger Global Management
- TogetherMD
- Torrey Pines
- TouchPointCare
- Transtek
- Trapollo
- TYLT Ventures
- TytoCare
- U.S. Army Medical Research and Development Command (USAMRDC)
- Unilever Ventures
- Union Chimique Belge
- UnitedHealth
- University Growth Fund
- University of Colorado
- Updata Partners
- UPMC
Methodology
LOADING...
